Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer

Cancer statistics, 2023

(2023) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Editorial: Attention to finer-details: Progression from bulk to single-cell studies

(2023) Pankaj Dwivedi   Translational Oncology

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Programme of self-reactive innate-like T cell-mediated cancer immunity

(2022) Chun Chou et al.   NATURE

Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer

(2022) Winston R. Becker et al.   NATURE GENETICS

P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells

(2022) Pedro Vargas et al.   Purinergic Signalling

Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y6 receptor antagonists

(2022) Young-Hwan Jung et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Colorectal Cancer and Purinergic Signalling: An Overview

(2022) Gabriela Roliano et al.   Cancers

P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications

(2021) Lucas T. Woods et al.   BIOCHEMICAL PHARMACOLOGY

Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study

(2021) Jiang Lin et al.   PeerJ

Control of Macrophage Inflammation by P2Y Purinergic Receptors

(2021) Dominik Klaver et al.   Cells

P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment

(2021) Fernanda Bueno Morrone et al.   MOLECULES

DNA mismatch repair in the context of chromatin

(2020) Yaping Huang et al.   Cell and Bioscience

NLRC4, ASC and Caspase-1 Are Inflammasome Components That Are Mediated by P2Y2R Activation in Breast Cancer Cells

(2020) Hana Jin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The efficacy and safety comparison of PD-1/PD-L1 antibody, chemotherapy and supportive treatment for pretreated advanced esophagogastric cancer: a network meta-analysis

(2020) Chuan Liu et al.   Annals of Palliative Medicine

Extracellular ATP modulates podocyte function through P2Y purinergic receptors and pleiotropic effects on AMPK and cAMP/PKA signaling pathways

(2020) Maria Szrejder et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines

(2020) Lucas T. Woods et al.   ORAL ONCOLOGY

P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway

(2020) Aline Zaparte et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Purine Release, Metabolism, and Signaling in the Inflammatory Response

(2019) Joel Linden et al.   Annual Review of Immunology

Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis

(2019) Hsin-Ling Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent

(2019) Hien Thi Thu Le et al.   Scientific Reports

The G protein-coupled P2Y 6 receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis

(2018) Morgane Placet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

EMT Transition States during Tumor Progression and Metastasis

(2018) Ievgenia Pastushenko et al.   TRENDS IN CELL BIOLOGY

Pharmacology and structure of P2Y receptors

(2016) Ivar von Kügelgen et al.   NEUROPHARMACOLOGY

Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells

(2015) Iman Azimi et al.   Molecular Oncology

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2015) Hossein Borghaei et al.   NEW ENGLAND JOURNAL OF MEDICINE

The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells

(2012) Youness Limami et al.   BIOCHIMIE